Radiotherapy with Durvalumab vs. Cetuximab in Patients with Locoregionally Advanced Head and Neck Cancer and a Contraindication to Cisplatin: Phase II Results of NRG-HN004

Loren K. Mell, P. Torres-Saavedra, Stuart J. Wong, S. Chang, J.A. Kish, A.J. Minn, R. Jordan, T. Liu, M.T. Truong, Eric W Winquist, T. Wise-Draper, Cristina P. Rodriguez, A. Musaddiq, B.M. Beadle, C. Henson, S. Narayan, S.A. Spencer, J. Harris, S.S. Yom